A rare case of aggressive, hereditary paraganglioma associated with a pathogenic variant in SDHD.
暂无分享,去创建一个
A. Hubalewska-Dydejczyk | R. Tomaszewska | A. Skalniak | E. Przybylik-Mazurek | M. Buziak-Bereza | A. Brzozowska-Czarnek | Anna Kurzyńska
[1] A. Gimenez-Roqueplo,et al. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma. , 2020, Best practice & research. Clinical endocrinology & metabolism.
[2] R. D. de Krijger,et al. Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of Origin , 2019, Cancers.
[3] W. Drake,et al. Can subunit‐specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers? , 2018, Clinical endocrinology.
[4] E. Jordanova,et al. Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families , 2004, Oncogene.